MXPA03006722A - Nueva sal de tiazolidindiona y sus polimorfos como agentes antidiabeticos y metodo para la obtencion de los mismos. - Google Patents

Nueva sal de tiazolidindiona y sus polimorfos como agentes antidiabeticos y metodo para la obtencion de los mismos.

Info

Publication number
MXPA03006722A
MXPA03006722A MXPA03006722A MXPA03006722A MXPA03006722A MX PA03006722 A MXPA03006722 A MX PA03006722A MX PA03006722 A MXPA03006722 A MX PA03006722A MX PA03006722 A MXPA03006722 A MX PA03006722A MX PA03006722 A MXPA03006722 A MX PA03006722A
Authority
MX
Mexico
Prior art keywords
polymorphs
thiazolidinedione
obtaining
new salt
antidiabetic agents
Prior art date
Application number
MXPA03006722A
Other languages
English (en)
Inventor
Marquillas Olondriz Francisco
Original Assignee
Vita Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vita Lab filed Critical Vita Lab
Publication of MXPA03006722A publication Critical patent/MXPA03006722A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

Esta invencion se refiere a una nueva sal de 5-(4-{2 -[(6-metoxi- pirimidin-4 -il)-metil-amino] -etoxi}-bencil) -tiazolidin-2, 4-diona y sus polimorfos que tiene una actividad hipoglucemiante elevada y, que por lo tanto, son potencialmente utiles en el tratamiento y/o profilaxis de la diabetes y/o otras alteraciones o complicaciones propias de la diabetes, como hiperglicemia o hiperlipidemia; esta invencion tambien se refiere a un metodo para la elaboracion de los mismos.
MXPA03006722A 2001-01-31 2002-01-21 Nueva sal de tiazolidindiona y sus polimorfos como agentes antidiabeticos y metodo para la obtencion de los mismos. MXPA03006722A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200100273A ES2174748B1 (es) 2001-01-31 2001-01-31 Nueva sal de tiazolidindiona y sus polimorfos como agentes antidiabeticos y procedimiento para la obtencion de los mismos.
PCT/IB2002/000229 WO2002060899A1 (en) 2001-01-31 2002-01-21 New salt of thiazolidinedione and its polymorphs as antidiabetic agents and method for obtaining them

Publications (1)

Publication Number Publication Date
MXPA03006722A true MXPA03006722A (es) 2004-10-15

Family

ID=8496644

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03006722A MXPA03006722A (es) 2001-01-31 2002-01-21 Nueva sal de tiazolidindiona y sus polimorfos como agentes antidiabeticos y metodo para la obtencion de los mismos.

Country Status (27)

Country Link
US (1) US20040106632A1 (es)
EP (1) EP1355908A1 (es)
JP (1) JP2004529870A (es)
KR (1) KR20030078893A (es)
CN (1) CN1694881A (es)
AP (1) AP1281A (es)
AR (1) AR042584A1 (es)
BG (1) BG108047A (es)
BR (1) BR0206850A (es)
CA (1) CA2436556A1 (es)
CZ (1) CZ20032015A3 (es)
EA (1) EA200300842A1 (es)
EE (1) EE200300356A (es)
ES (1) ES2174748B1 (es)
HU (1) HUP0302871A2 (es)
IL (1) IL157028A0 (es)
IS (1) IS6896A (es)
MA (1) MA26988A1 (es)
MX (1) MXPA03006722A (es)
NO (1) NO20033375L (es)
NZ (1) NZ527677A (es)
PE (1) PE20020969A1 (es)
PL (1) PL362527A1 (es)
SK (1) SK9552003A3 (es)
WO (1) WO2002060899A1 (es)
YU (1) YU60303A (es)
ZA (1) ZA200305873B (es)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0842925A1 (en) * 1987-09-04 1998-05-20 Beecham Group Plc Substituted thiazolidinedione derivatives
CN1183130C (zh) * 1999-09-24 2005-01-05 中国人民解放军军事医学科学院毒物药物研究所 噻唑烷类衍生物及其医药用途
ES2156574B1 (es) * 1999-11-18 2002-02-01 Vita Invest Sa Nuevos derivados de tiazolidindiona como agentes antidiabeticos

Also Published As

Publication number Publication date
AP1281A (en) 2004-05-25
ZA200305873B (en) 2004-07-30
YU60303A (sh) 2006-05-25
BG108047A (bg) 2004-08-31
BR0206850A (pt) 2004-01-13
EA200300842A1 (ru) 2004-04-29
ES2174748B1 (es) 2003-09-16
NZ527677A (en) 2005-01-28
WO2002060899A1 (en) 2002-08-08
MA26988A1 (fr) 2004-12-20
NO20033375L (no) 2003-08-22
CZ20032015A3 (cs) 2004-02-18
US20040106632A1 (en) 2004-06-03
EP1355908A1 (en) 2003-10-29
ES2174748A1 (es) 2002-11-01
AP2003002832A0 (en) 2003-09-30
CN1694881A (zh) 2005-11-09
NO20033375D0 (no) 2003-07-28
IL157028A0 (en) 2004-02-08
PE20020969A1 (es) 2002-12-04
EE200300356A (et) 2003-10-15
PL362527A1 (en) 2004-11-02
IS6896A (is) 2003-07-28
JP2004529870A (ja) 2004-09-30
KR20030078893A (ko) 2003-10-08
HUP0302871A2 (hu) 2003-12-29
AR042584A1 (es) 2005-06-29
SK9552003A3 (en) 2004-05-04
CA2436556A1 (en) 2002-08-08

Similar Documents

Publication Publication Date Title
WO2004050645A8 (en) Substituted (thiazol-2-yl) -amide or sulfonamide as glycokinase activators useful in the treatment of type 2 diabetes
NO20051103L (no) Indol-3-karboksamider som Glukokinase-(GK)-Aktivatorer
WO2006012395A3 (en) Peptidase inhibitors
RS93604A (en) Substituted phenylacetamides and their use as glucokinase activators
MY141521A (en) 5-substituted-six-membered heteroaromatic glucokinase activators
CA2407416A1 (en) Alkynyl phenyl heteroaromatic glucokinase activators
ZA200604719B (en) DPP-IV inhibitors
TW200505919A (en) DPP-IV inhibitors
MY148809A (en) Crystals of 1,2-dihydropyridine compound and their production process
CA2407759A1 (en) Substituted phenylacetamides and their use as glucokinase activators
MXPA03006918A (es) Compuestos heterociclicos fusionados.
TW200738136A (en) Fungicidal N-[2-(haloalkoxy)phenyl]heteroarylcarboxamides
WO2005012318A3 (en) Substituted fused heterocyclic c-glycosides
MY136926A (en) Glucokinase activators
CO5690637A2 (es) Tiazol-(bi) cicloalquil-carboxanilidas
PL371582A1 (en) Difluoromethyl thiazolyl carboxanilides
UA85569C2 (ru) Замещенные конденсированные гетероциклические с-гликозиды
UA81659C2 (ru) Моноклинный 2-хлор-n-(4'-хлорбифенил-2-ил)никотинамид, способ его получения, фунгицидное средство и способ борьбы с вредными грибами
IL120443A0 (en) Heterocyclic compounds for the treatment of pancreatitis
ES2174748A1 (es) Nueva sal de tiazolidindiona y sus polimorfos como agentes antidiabeticos y procedimiento para la obtencion de los mismos.
TWI318625B (en) Process for the preparation of 2-aminomethylpyridine derivative
EP1251847A4 (en) NEW USE OF PRODIGIOSIN FOR THE TREATMENT OF DIABETES MELLITUS
MXPA05009478A (es) Pirimidinas de piridilsulfonamido para tratar neuropatia diabetica.
PL373280A1 (en) Process for the preparation of modification i of n-(1-methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridinesulfonamide
RS20060321A (en) Substituted fused heterocyclic c-glycosides

Legal Events

Date Code Title Description
FA Abandonment or withdrawal